Preventive role of carvedilol in adriamycin-induced cardiomyopathy

BACKGROUND & OBJECTIVES: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in can...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Med Res
Autors principals: Jhorawat, Rajesh, Kumari, Savita, Varma, Subhash C., Rohit, Manoj K., Narula, Nidhi, Suri, Vikas, Malhotra, Pankaj, Jain, Sanjay
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5393084/
https://ncbi.nlm.nih.gov/pubmed/28361826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_1323_14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars